slides · global inventory
Legend
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 13,863
Current window 10,291-10,320
Pages 463
Rows per page 30
Component
10,291-10,320 of 13,863
36
The slide uses a timeline framework to map patent coverage and exclusivity periods across two main product categories.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
05
The table uses a heatmap-style color coding where red indicates existing targeted therapy markets and teal indicates blue ocean opportunities.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Introduction to Erasca and RAS/MAPK pathwayLoop · Logic Chain1 hit
06
The diagram illustrates a biological signaling pathway with specific nodes highlighted as targets for the company's therapeutic approach.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Challenges in current cancer treatment and unmet needsLoop · Logic Chain1 hit
07
The slide uses a Gantt-style visualization for clinical trial progress.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Challenges in current cancer treatment and unmet needsLoop · Logic Chain1 hit
18
The slide uses a swimmer plot to visualize individual patient treatment duration and response status.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical dataLoop · Cost Of Inaction1 hit
22
The chart displays adverse events occurring in >=10% of patients (n=15).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
39
The chart is a Kaplan-Meier survival plot. The comparison shows ERAS-801 (blue line) outperforming standard EGFR inhibitors (Erlotinib, Lapatinib, Osimertinib) and vehicle control.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
41
The slide uses a waterfall plot to show individual model responses and pie charts to summarize efficacy across the total cohort vs. the specific EGFR-mutant/amplified subset.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
51
The chart displays individual patient treatment timelines, with markers for partial response, stable disease, and progressive disease.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
10
The chart combines historical bar data with a waterfall bridge to illustrate future growth drivers.Essity | Investor Presentation Deck | 13 slides · Essity
Conference presentation Investor relations Beat · ClimaxLoop · Why Now1 hit
09
The slide uses a linear representation of orbital slots overlaid on a world map to visualize satellite distribution.Eutelsat | Investor Presentation Deck | 63 slides · Eutelsat Group
Conference presentation Investor relations 1 hit
10
Includes a specific callout for insurance proceeds in FY 2020-21.Eutelsat | Investor Presentation Deck | 63 slides · Eutelsat Group
Conference presentation Investor relations 1 hit
19
The slide highlights the growth gap in fiber penetration, specifically calling out Eutelsat's main markets.Eutelsat | Investor Presentation Deck | 63 slides · Eutelsat Group
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
12
The slide uses a stepped arrow diagram to show progression from known targets to challenging novel targets.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
22
The slide uses a hierarchical clustering heatmap (dendrograms on top and left) to visualize drug sensitivity across 80 small molecules.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
35
The table uses a color-coded heatmap to indicate performance against criteria.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
38
The slide uses a heatmap to correlate '617 sensitivity with synergy outcomes for three different drug combinations.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
42
The slide uses a traffic-light color coding system to highlight the competitive advantage of the company's drug candidate.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
52
The slide uses a traffic-light color coding system to indicate performance against criteria.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
54
The chart illustrates a Pareto front in drug discovery, highlighting that the 'best' molecules (on the front) are not always the most information-rich for further development.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
68
The slide uses a heatmap-style table to visualize performance against criteria, with a specific callout box around the UGT1A1 row.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
13
Features a photo of a Google I/O keynote, a screenshot of the ChatGPT plugin store, and a logo grid of Microsoft/OpenAI plugin developers.FiscalNote | Investor Presentation Deck | 33 slides · FiscalNote
Pitch deck Investor relations 1 hit
20
The slide illustrates the dual revenue stream model of the company.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
17
The chart shows FPI-1434 Plasma AUC for two different dosing regimens.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
18
The slide highlights a specific program (Program 1) involving dual targeting of EGFR and cMET using Fusion's FastClear linker technology.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
09
The slide uses a table-like layout to compare market sizes and brand presence across different lifestyle verticals.Hagerty | Investor Presentation Deck | 24 slides · Hagerty
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The chart tracks loan portfolio composition over time, highlighting the growth in operating company relationships.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Satisfaction1 hit
40
The slide uses a waterfall chart for the credit loss allowance and a stacked bar chart for the allowance percentage trends.Heartland Financial USA | Results Presentation Deck | 55 slides · Heartland Financial USA
Conference presentation Investor relations Beat · Action1 hit
08
The chart uses a line for sales and bars for EBIT margin, with a clear inflection point post-2020.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations Beat · Solution1 hit
09
The chart uses a highlight color for Hugo Boss to emphasize its position at the top of the peer set.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations Beat · Solution1 hit